Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Artelac Complete is a preservative-free ophthalmic lubricating solution indicated for the treatment of dry eye disease (dry eye syndrome). Classified as a CE-marked medical device and manufactured by Bausch & Lomb (specifically Dr. Gerhard Mann chem.-pharm. Fabrik GmbH), it features a formulation containing hyaluronic acid (as sodium hyaluronate), carbomer, glycerol, and medium-chain triglycerides. These components work synergistically to mimic the three layers of the natural tear film (aqueous, mucin, and lipid), providing long-lasting hydration and lubrication to the ocular surface. The product is typically delivered via a multidose bottle (MDO technology) that maintains sterility without the need for preservatives, making it suitable for patients with sensitive eyes or those requiring frequent application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Artelac Complete.